Guide for Aviation Medical Examiners
Decision Considerations – Aerospace Medical Dispositions
Item 41. G-U System – Neoplastic Disorders
|A. Benign Prostatic Hypertrophy (BPH) or elevated PSA||If the airman has findings consistent with uncomplicated BPH with no evidence of prostate cancer:||ISSUE
Summarize this history in Block 60
Notes: See Pharmaceuticals section for list of medications usually allowed.
|A. Prostate Cancer
Non metastatic with treatment completed 5 or more years ago
|If NO recurrence or ongoing treatment:||ISSUE
Summarize this history in Block 60.
|B. Prostate Cancer
Non metastatic with treatment completed less than 5 years ago or active surveillance / watchful waiting.
|Follow CACI worksheet.||Follow the CACI – Prostate Cancer Worksheet. Note in Block 60.|
|C. Prostate Cancer with Metastatic disease current OR any time in the past
Recurrence of disease including a biochemical recurrence (BCR) after prostatectomy
|Submit the following to the FAA review:
☐ Current status report from oncologist describing treatment plan, how long the condition has been stable, and prognosis;
☐ List of medications and presence or absence of side effects with specific attention to any chemotherapy, steroids, or hormone agents and dates used;
☐ Treatment records including clinic notes or a summary letter describing initial staging, disease course, locations of metastatic disease, and stability;
☐ Operative notes and discharge summary, if applicable;
☐ Pathology report(s), if applicable; and
☐ Results of MRI/CT or PET scan reports. (In some cases, the actual CDs will be required in DICOM format for FAA review).
Initial Special Issuance – Requires FAA Decision
Follow up Special Issuance will be per the airman's authorization letter
Notes: If the airman is currently on radiation or chemotherapy, the treatment course should be completed before medical certification can be considered.